Ascendis Pharma A/S (ASND) Earnings Date & Reports

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ASND is expected to report earnings to rise 129.69% to -147 cents per share on May 21

Ascendis Pharma A/S ASND Stock Earnings Reports

Q1'25

Est.

$-1.47

Q4'24

Beat

by $0.34

Q3'24

Missed

by $0.18

Q2'24

Missed

by $0.45

Q1'24

Missed

by $0.82

The last earnings report on February 12 showed earnings per share of -63 cents, beating the estimate of -98 cents. With 363.14K shares outstanding, the current market capitalization sits at 9.65B.

View a ticker or compare two or three

Compare

ASND